Denny M. Lanfear
CEO and Chairman, Coherus BioSciences
Denny Lanfear is a biopharmaceutical leader and biosimilar pioneer with a proven track record of successful entrepreneurial vision and achievement. In 2010, after decades working in the biopharmaceutical industry, he founded Coherus BioSciences
with the vision of improving the public’s access to high-quality, life-changing medicines. Under Mr. Lanfear’s leadership as CEO and Chairman, Coherus BioSciences has transformed from an unfunded startup into the industry’s leading pure play biosimilar company. In addition, he has led its foray into innovative cancer therapeutics in 2021.
Vice President of Government Affairs, Teva Pharmaceuticals
Michael Brzica is currently Vice President, Government Affairs for Teva Pharmaceuticals. In this role, Brzica leads the company’s interface with state and federal policymakers in legislative and executive branches. Prior to joining Teva, Brzica held roles of increasing responsibility at the Association for Accessible Medicines, a Washington, D.C. trade association representing manufacturers of generic and biosimilar medicines. In addition to these roles, Brzica worked in government affairs capacities at Prime Therapeutics and the American Dental Association. He began his career in Washington as counsel to former U.S. Representative Lee Terry (R-NE). Brzica holds a B.S. and J.D. from Creighton University in Omaha, Nebraska and currently resides in Alexandria, Virginia with his wife Lindsey, their son Henry, and dog Morris.
David T. Sanders
SAMS Executive Director
Vice President, Government Affairs and Policy, Coherus BioSciences
David Sanders has more than twenty years of experience working in government and industry. He worked for Senator Fred Thompson (R-TN), then-Representative Marsha Blackburn (R-TN), and Bush-Cheney 2004. He served as a legislative liaison for the U.S. Patent and Trademark Office, working on intellectual property and trade law. He advanced policy working for Teva Pharmaceuticals USA, National Community Pharmacists Association and DaVita Inc. before joining Coherus BioSciences
in the summer of 2020 where he leads a small team in policy, advocacy and public affairs.
A serial entrepreneur, industry pioneer, sought after speaker and international healthcare consultant, Tony has been in leadership positions his entire life; and intimately understands the unique opportunities, challenges, thrill, frustration and loneliness often associated with being an industry game-changer. Over the past three decades, he has founded and led numerous public and private companies and organizations and is a recognized expert in a broad range of markets, not the least of which is Retail Healthcare, an industry he is credited for pioneering.
Howard A. Crawford
Vice President, Government Business and Health Policy, Amneal Pharmaceuticals
Howard joined the United States Air Force in 1987 as a Medical Service Technician. He was promoted through the ranks and obtained the rank of Technical Sergeant. He received a direct commissioning as a Medical Service Corps Officer in 1996. He worked as a readiness officer and Tricare officer. Howard retired from the Air Force Reserve in 2007 as a Captain. He is currently an Air Force Academy Admissions Liaison Officer in Eastern PA for the last 20 years and still serving.
Howard has held several positions in the pharmaceutical and capital equipment industry. He is currently Vice President, Government Business and Health Policy at Amneal Pharmaceuticals. Prior to that he was Vice President of Sales at Lovell Government Services. A Service-Disabled Veteran Owned Small business. Howard was Chairman of AMSUS SM in 2009, and is a Life member of AMSUS. A society for Federal Healthcare Professionals. He was recently appointed the first Chairman Emeritus.
He resides in West Chester, PA with his wife Debbie and their two sons, Matthew and Brian. Howard is Commander of American Legion Post 134, Current President of the West Chester Veterans Council, A member of the Disabled American Veterans and sits on two U.S. Congressional Academy Boards.
Senior Director, Commercial Strategy, Mallinckrodt Pharmaceuticals
Andrew joined SpecGx in 2019, and currently is responsible for Commercial, Business Development and Strategy for Mallinckrodt Specialty Generics (SpecGx). Prior to joining SpecGx, he worked in strategy, operations, and quality at Mundipharma, Hospira, and McKinsey & Co. Over his 20-year career, he has worked across 20+ pharmaceutical plants on four continents. He has an MBA from the University of Virginia, and a Master and Bachelors in Engineering from Duke University and currently lives in Raleigh, NC.
Stephen R. Conafay
SAMS Secretary and Washington Counsel
Steve Conafay has 35 years of leadership and management experience in government relations, public policy and communications. For 12 years, Mr. Conafay was vice president of government relations for Pfizer, where he was elected as a corporate officer in 1984. He served as senior vice president of corporate affairs for Glaxo Inc., where he was also a member of the Board of Directors. After heading the legislative practice for Jones, Day, Reavis and Pogue, he was tapped by the Pharmaceutical Research and Manufacturers of America (PhRMA) to assume the No. 2 position of executive vice president of strategic and legislative affairs. He also served as an executive fellow at the American Enterprise Institute, the leading free market think tank in the U.S.